Following the Centers for Disease Control and Prevention's (CDC's) recommendation, U.S. Department of Health and Human Services Secretary Xavier Becerra has announced that Novavax's Covid-19 vaccine for adults will be made available to people aged 18 and above who require or prefer a protein-based vaccine.
CDC's recommendation comes barely a week after the Food and Drug Administration's authorization of the Novavax Covid-19 vaccine for emergency use in individuals 18 years and older as a primary vaccination series against COVID-19, and an Advisory Community on Immunization Practices' recommendation for use of this vaccine.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Joji Xavier
For comments and feedback: contact editorial@rttnews.com